Aspect Biosystems Announces $200 Million Partnership with the Governments of Canada and British Columbia to Advance Development of Bioprinted Tissue Therapeutics
Government investment in Aspect Biosystems will accelerate development of truly disease-modifying treatments and functional cures for people with serious metabolic and endocrine diseases VANCOUVER, BC – Aspect Biosystems, a biotechnology… Read More




